GENE ONLINE|News &
Opinion
Blog

PARP Inhibitor
EMA Recommends Restriction on Rubraca
2022-07-25
AZ, Merck’s PARP Inhibitor Shines in Phase 3 Prostate Cancer Trial
2021-09-26
Zai Lab, Schrödinger Collaborate to Advance Cancer Program
2021-08-05
Clovis Oncology’s PARP Inhibitor Shines in Preliminary Prostate Cancer Trial
2021-04-12
Understanding Cancer Chromosomal Instability: Highlights from the AACR2021 Discovery Science Plenary Session
2021-04-11
Lynparza Bags Multiple Approvals in Japan
2021-01-05
Tumor Drug Resistance Helps Identify a Novel Therapy for Leukemia
2020-10-11
#ESMO20: AZ, Merck’s PARP Inhibitor Surpasses Standard of Care in Prostate Cancer Trial
2020-09-22
Lynparza Notches EU Authorization for BRCA-Mutated Metastatic Pancreatic Cancer
2020-07-11
Lynparza Greenlighted by FDA for HRR-Mutated, Metastatic Prostate Cancer
2020-05-27
R&D
AACR 2020 Conference – Recent Advances in Breast Cancer Treatments
2020-04-29
AACR 2020 Conference – Opening Clinical Plenary Highlights
2020-04-28
Cancer Drug Resistance: Implications in Cancer Therapy
2020-04-20
Genentech’s Actemra gets FDA approval to begin COVID-19 Trials in April
2020-03-25
Japan Grants Orphan Drug Designation to Lynparza for Germline BRCA-mutated Pancreatic Cancer
2020-03-25
1 2
LATEST
Roche Reports Positive Clinical Trial Results for Two Diabetes-Related Eye Disease Therapies
2024-07-19
7th Person in History Possibly Cured From HIV After Stem Cell Transplant for Acute Myeloid Leukemia
2024-07-19
Large RCT Finds Time-Lapse Imaging for Embryo Selection in IVF Does Not Improve Live Birth Rates
2024-07-19
Assessment of Supply Chain Risk Key to Improving Medicine Access
2024-07-18
SK Biopharma and Full-Life Sign US$571.5 Million Deal for Innovative Radiopharmaceutical FL-091
2024-07-18
Autoimmune Patients See Breakthrough Response to Allogeneic CD19-Targeted CAR-T Therapy
2024-07-18
Rising Bird Flu Cases in Cattle and Humans Drive Global Efforts in Vaccination, Genetic Monitoring, and Surveillance
2024-07-17
EVENT
Scroll to Top